Literature DB >> 18178295

Active immunization against macrophage migration inhibitory factor using a novel DNA vaccine prevents ovariectomy-induced bone loss in mice.

Shin Onodera1, Shigeki Oshima, Jun Nishihira, Kazunori Yasuda, Harukazu Tohyama, Kazuharu Irie, Yoshikazu Koyama.   

Abstract

Previous studies have demonstrated that mice deficient in the macrophage migration inhibitory factor (MIF) gene are protected from ovariectomy (OVX)-induced bone loss. We developed a novel MIF-deoxyribonucleic acid (DNA) vaccine by introducing oligonucleotides encoding a helper T epitope into the cDNA sequence of murine MIF. Mice given the MIF-DNA vaccine produced high titers of autoantibody against MIF, and were protected from OVX-induced bone loss. Our results further support the hypothesis that MIF is involved in the pathomechanism of OVX-induced bone loss, and also show that active immunization against MIF using a DNA vaccine may be useful for the prophylactic treatment of postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18178295     DOI: 10.1016/j.vaccine.2007.11.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Authors:  Ran Gu; Leilani L Santos; Devi Ngo; HuaPeng Fan; Preetinder P Singh; Gunter Fingerle-Rowson; Richard Bucala; Jiake Xu; Julian M W Quinn; Eric F Morand
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

2.  Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.

Authors:  L Christine Turtzo; Jun Li; Rebecca Persky; Sharon Benashski; Gillian Weston; Richard Bucala; Venugopal Reddy Venna; Louise D McCullough
Journal:  Neurobiol Dis       Date:  2013-01-30       Impact factor: 5.996

3.  Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin.

Authors:  E Beaulieu; L Green; L Elsby; Z Alourfi; E F Morand; D W Ray; R Donn
Journal:  Clin Exp Immunol       Date:  2010-11-19       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.